Oms906

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

3 Countries

Phase II

Phase II: 2

Sponsors using this IMP

All trials

2 total

An Open-Label Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of OMS906 in Patients with Paroxysmal Nocturnal Hemoglobinur… Ended

2023-507413-10-00 Phase II 1 country Omeros Corp.
This study will use a new investigation study drug called OMS906 in peoplewith C3 Glomerulopathy (C3G) or Idiopathic Immune Complex-Mediated… Ended

2023-508669-33-00 Phase II 2 countries Omeros Corp.

Showing 1–2 of 2 trials

← All drugs A–Z